PTC Therapeutics Inc. buy Royal Bank of Canada
Start price
03.12.24
/
50%
€49.60
Target price
03.12.25
€59.86
Performance (%)
28.02%
End price
04.12.25
€63.50
Summary
This prediction ended on 04.12.25 with a price of €63.50. The BUY prediction by Royal_Bank_of_Canada finished with a performance of 28.02%. Royal_Bank_of_Canada has a follow-up prediction for PTC Therapeutics Inc. where he still thinks PTC Therapeutics Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| PTC Therapeutics Inc. | 4.675% | 4.675% | 48.537% |
| iShares Core DAX® | 3.593% | 6.427% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 6.381% | 41.455% |
| iShares Nikkei 225® | 4.075% | 9.307% | 48.947% |
| iShares S&P 500 | 4.142% | 4.938% | 31.594% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating. They now have a $63.00 price target on the stock, up previously from $39.00.
Ratings data for PTCT provided by MarketBeat
In the thread Trading PTC Therapeutics Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Current prediction by Royal_Bank_of_Canada for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€41.60
22.04.25
22.04.25
€56.55
22.04.26
22.04.26
44.42%
17.04.26
17.04.26
Stopped prediction by Royal_Bank_of_Canada for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€61.50
05.11.25
05.11.25
€71.35
05.11.26
05.11.26
0.78%
17.04.26
17.04.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€36.20
07.05.25
07.05.25
€51.13
07.05.26
07.05.26
71.22%
17.04.26
17.04.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€47.40
18.02.25
18.02.25
€60.28
18.02.26
18.02.26
22.36%
19.02.26
19.02.26